Cargando…

Dolutegravir-based anti-retroviral therapy is effective and safe in HIV–infected paediatric patients

BACKGROUND: Treatment of HIV infection in adolescents is challenging due to long duration of therapy and poor adherence. Recently, the integrase strand transfer inhibitor dolutegravir (DTG) has been approved for the use in adolescents with HIV, but evidence in clinical practice is very limited. METH...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bruzzese, Eugenia, Lo Vecchio, Andrea, Smarrazzo, Andrea, Tambaro, Orsola, Palmiero, Giulia, Bonadies, Giovanni, Guarino, Alfredo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5859652/ https://www.ncbi.nlm.nih.gov/pubmed/29558972 http://dx.doi.org/10.1186/s13052-018-0469-x

Ejemplares similares

The Transition of Care From Pediatric to Adult Health-Care Services of Vertically HIV-Infected Adolescents: A Pilot Study
por: Continisio, Grazia Isabella, et al.
Publicado: (2020)

Endobronchial primary large B-cell Non-Hodgkin lymphoma in HIV-infected patient in the Highly Active Antiretroviral Therapy era: Description of a case report
por: Caterino, U., et al.
Publicado: (2017)

The promise of paediatric dolutegravir
por: Golin, Rachel, et al.
Publicado: (2021)

Effects of COVID-19 pandemic on pediatric tuberculosis: decrease in notification rates and increase in clinical severity
por: Lo Vecchio, Andrea, et al.
Publicado: (2023)

No Spread of SARS-CoV-2 From Infected Symptomatic Children to Parents: A Prospective Cohort Study in a Controlled Hospital Setting
por: Nunziata, Francesco, et al.
Publicado: (2021)

Potency of Oral Rehydration Solution in Inducing Fluid Absorption is Related to Glucose Concentration
por: Buccigrossi, Vittoria, et al.
Publicado: (2020)

Postbiotic Preparation of Lacticaseibacillus rhamnosus GG against Diarrhea and Oxidative Stress Induced by Spike Protein of SARS-CoV-2 in Human Enterocytes
por: Poeta, Marco, et al.
Publicado: (2023)

Probing Resistance Mutations in Retroviral Integrases by Direct Measurement of Dolutegravir Fluorescence
por: Thierry, Eloïse, et al.
Publicado: (2017)

Clinical Presentation and Severity of SARS-CoV-2 Infection Compared to Respiratory Syncytial Virus and Other Viral Respiratory Infections in Children Less than Two Years of Age
por: Nunziata, Francesco, et al.
Publicado: (2023)

Peritoneal tuberculosis mimicking carcinomatous ascites in a child living in a low prevalence country: a case report
por: Rossi, Alessandro, et al.
Publicado: (2020)

Bradycardia associated with Multisystem Inflammatory Syndrome in Children with COVID-19: a case series
por: Ciccarelli, Gian Paolo, et al.
Publicado: (2021)

Blood glucose outcomes of anti-retroviral therapy naïve Ugandan people with HIV with pre-diabetes mellitus initiated on dolutegravir for 48 weeks
por: Mulindwa, Frank, et al.
Publicado: (2023)

Protection of Vaccine Preventable Diseases in a Population of HIV-Infected Children: A 3 Years Prospective Study
por: Bruzzese, Eugenia, et al.
Publicado: (2021)

Health-care organization for the management and surveillance of SARS-CoV-2 infection in children during pandemic in Campania region, Italy
por: Nunziata, Francesco, et al.
Publicado: (2020)

COVID-19-associated severe mono-hemispheric encephalitis in a young infant
por: Nunziata, Francesco, et al.
Publicado: (2022)

Factors associated with uptake of contraceptives among HIV positive women on dolutegravir based anti-retroviral treatment-a cross sectional survey in urban Uganda
por: Mbabazi, Leah, et al.
Publicado: (2022)

Antibiotic treatment of acute gastroenteritis in children
por: Bruzzese, Eugenia, et al.
Publicado: (2018)

AntiRetroviral Therapy In Second-line: investigating Tenofovir-lamivudine-dolutegravir (ARTIST): protocol for a randomised controlled trial
por: Zhao, Ying, et al.
Publicado: (2021)

Disrupted Intestinal Microbiota and Intestinal Inflammation in Children with Cystic Fibrosis and Its Restoration with Lactobacillus GG: A Randomised Clinical Trial
por: Bruzzese, Eugenia, et al.
Publicado: (2014)

Diarrhea Is a Hallmark of Inflammation in Pediatric COVID-19
por: Poeta, Marco, et al.
Publicado: (2022)

Management of children with prolonged diarrhea
por: Giannattasio, Antonietta, et al.
Publicado: (2016)

In-vivo pharmacokinetic studies of Dolutegravir loaded spray dried Chitosan nanoparticles as milk admixture for paediatrics infected with HIV
por: K, Priya Dharshini, et al.
Publicado: (2022)

The role of dolutegravir in the management of HIV infection
por: Miller, Misty M, et al.
Publicado: (2015)

Provider perspectives on the acceptability and tolerability of dolutegravir-based anti-retroviral therapy after national roll-out in Uganda: a qualitative study
por: Zakumumpa, Henry, et al.
Publicado: (2021)

Dolutegravir plus lamivudine for hiv treatment: Does the historical genotype really matter?
por: Giacomelli, Andrea, et al.
Publicado: (2020)

Clinical effectiveness of dolutegravir in the treatment of HIV/AIDS
por: Taha, Huda, et al.
Publicado: (2015)

Dolutegravir/rilpivirine for the treatment of HIV-1 infection
por: Dowers, Ellen, et al.
Publicado: (2018)

Should dolutegravir always be withheld in people with HIV on dolutegravir with incident diabetes mellitus? A case report
por: Mulindwa, Frank, et al.
Publicado: (2023)

Knowledge and perceptions about Dolutegravir and Dolutegravir counselling: a qualitative study among women living with HIV
por: Chapola, John C., et al.
Publicado: (2023)

Should dolutegravir always be withheld in people with HIV on dolutegravir with incident diabetes mellitus? a case report
por: Mulindwa, Frank, et al.
Publicado: (2023)

Dolutegravir is not associated with weight gain in antiretroviral therapy experienced geriatric patients living with HIV
por: Guaraldi, Giovanni, et al.
Publicado: (2021)

SARS-CoV-2 causes secretory diarrhea with an enterotoxin-like mechanism, which is reduced by diosmectite
por: Poeta, Marco, et al.
Publicado: (2022)

Implementation of longitudinal insulin kinetic studies in busy field settings in Uganda: experience from the “glucose metabolism changes in Ugandan HIV patients on dolutegravir based anti-retroviral therapy” (GLUMED study)
por: Mulindwa, Frank, et al.
Publicado: (2023)

Breaking the unbreakable: A paediatric case of dolutegravir resistance from KwaZulu-Natal
por: Malinga, Sibongiseni, et al.
Publicado: (2023)

First case report of a perinatally HIV-infected infant with HIV resistance to dolutegravir associated with tenofovir/lamivudine/dolutegravir use in mothers
por: Francois, Kesner, et al.
Publicado: (2023)

Role of Early Life Cytotoxic T Lymphocyte and Natural Killer Cell Immunity in Paediatric HIV Cure/Remission in the Anti-Retroviral Therapy Era
por: Vieira, Vinicius A., et al.
Publicado: (2022)

HIV–1 resistance to dolutegravir: update and new insights
por: Wainberg, Mark A, et al.
Publicado: (2015)

Switch to dolutegravir is well tolerated in Thais with HIV infection
por: Goh, Orlanda Q, et al.
Publicado: (2019)

Dolutegravir And Lamivudine Combination For The Treatment Of HIV-1 Infection
por: Zamora, Francis J, et al.
Publicado: (2019)

Dolutegravir Resistance in Malawi’s National HIV Treatment Program
por: van Oosterhout, Joep J, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_n7bojdi5ncj7c5os497c3g5bdr